Hybritech Inc said the U.S.Supreme Court denied a petition by Monoclonal Antibodies Incasking the court to review the validity of a Hybritech patent.    The patent covers a method of using monoclonal antibodiesin certain immunoassay tests to detect and monitor conditionssuch as pregnancy, cancer and infectious disease.    Hybritech sued Monoclonal in March 1984 for infringement ofits patent. Reuter&#3;